Machine learning identifies fatigue as a key symptom of fibromyalgia reflected in tyrosine, purine, pyrimidine, and glutaminergic metabolism

Abstract Fibromyalgia patients vary in clinical phenotype and treatment can be challenging. The pathophysiology of fibromyalgia is incompletely understood but appears to involve metabolic changes at rest or in response to stress. We enrolled 54 fibromyalgia patients and 31 healthy controls to this p...

Full description

Saved in:
Bibliographic Details
Main Authors: Teemu Zetterman (Author), Anni I. Nieminen (Author), Ritva Markkula (Author), Eija Kalso (Author), Jörn Lötsch (Author)
Format: Book
Published: Wiley, 2024-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_0b7ccc93e9d34b70bab4dc336d4119a2
042 |a dc 
100 1 0 |a Teemu Zetterman  |e author 
700 1 0 |a Anni I. Nieminen  |e author 
700 1 0 |a Ritva Markkula  |e author 
700 1 0 |a Eija Kalso  |e author 
700 1 0 |a Jörn Lötsch  |e author 
245 0 0 |a Machine learning identifies fatigue as a key symptom of fibromyalgia reflected in tyrosine, purine, pyrimidine, and glutaminergic metabolism 
260 |b Wiley,   |c 2024-03-01T00:00:00Z. 
500 |a 1752-8062 
500 |a 1752-8054 
500 |a 10.1111/cts.13740 
520 |a Abstract Fibromyalgia patients vary in clinical phenotype and treatment can be challenging. The pathophysiology of fibromyalgia is incompletely understood but appears to involve metabolic changes at rest or in response to stress. We enrolled 54 fibromyalgia patients and 31 healthy controls to this prospective study. Symptoms were assessed using the Fibromyalgia Impact Questionnaire (FIQ) and blood samples were collected for metabolomics analysis at baseline and after an oral glucose tolerance test and a cardiopulmonary exercise test. We identified key symptoms of fibromyalgia and related them to changes in metabolic pathways with supervised and unsupervised machine learning methods. Algorithms trained with the FIQ information assigned the fibromyalgia diagnosis in new data with balanced accuracy of 88% while fatigue alone already provided the diagnosis with 86% accuracy. Supervised analyses reduced the metabolomic information from 77 to 13 key markers. With these metabolites, fibromyalgia could be identified in new cases with 79% accuracy. In addition, 5‐hydroxyindole‐3‐acetic acid and glutamine levels correlated with the severity of fatigue. Patients differed from controls at baseline in tyrosine and purine pathways, and in the pyrimidine pathway after the stress challenges. Several key markers are involved in glutaminergic neurotransmission. This data‐driven analysis highlights fatigue as a key symptom of fibromyalgia. Fibromyalgia is associated with metabolic changes which also reflect the degree of fatigue. Responses to metabolic and physical stresses result in a metabolic pattern that allows discrimination of fibromyalgia patients from controls and narrows the focus on key pathophysiological processes in fibromyalgia as treatment targets. 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Clinical and Translational Science, Vol 17, Iss 3, Pp n/a-n/a (2024) 
787 0 |n https://doi.org/10.1111/cts.13740 
787 0 |n https://doaj.org/toc/1752-8054 
787 0 |n https://doaj.org/toc/1752-8062 
856 4 1 |u https://doaj.org/article/0b7ccc93e9d34b70bab4dc336d4119a2  |z Connect to this object online.